Home  >  News
Eppen_Q12025_Mar25
you can get e-magazine links on WhatsApp. Click here
News
  EnteroBiotix reports positive results from TrIuMPH phase 2a trial of EBX-102-02 in adults with irritable bowel syndrome with constipation,   March 19, 2025
  AstraZeneca announces CALYPSO phase III trial of eneboparatide meets primary endpoint of normalising serum calcium in adults with hypoparathyroidism at 24 weeks,   March 18, 2025
  Anocca announces authorisation of clinical trial application to start first in-human trial in advanced pancreatic cancer,   March 18, 2025
  Roche to present latest scientific advancements from its neuromuscular portfolio at Muscular Dystrophy Association 2025 conference,   March 18, 2025
  Eton Pharma announces positive results from bioequivalence study of ET-600 to treat central diabetes insipidus,   March 17, 2025
  Trial Library collaborates with American Oncology Network to expand clinical trial access for patients with various cancers,   March 15, 2025
  Bayer to present research on late-stage compound elinzanetant and impact on menopause symptoms at ESG 2025,   March 15, 2025
  Merck announces positive data from phase 3 trials that show the investigational, once-daily, oral, two-drug regimen of doravirine/islatravir maintained HIV-1 viral suppression at week 48,   March 15, 2025
  NIH-sponsored trial data shows tecovirimat is safe but ineffective as treatment for clade II mpox,   March 15, 2025
  PolyPid completes enrollment in phase 3 SHIELD II trial of D-PLEX100 for prevention of abdominal colorectal surgical site infections,   March 13, 2025
  QurAlis announces positive data from phase 1 trial of QRL-101 evaluating biomarkers of ALS and epilepsy in healthy volunteers,   March 13, 2025
  ViiV Healthcare showcases leadership in long-acting injectables innovation at CROI 2025 with data on third-generation integrase inhibitor and highly potent capsid inhibitor against HIV-1,   March 13, 2025
  Biogen begins TRANSCEND phase 3 study of felzartamab to treat late antibody-mediated rejection in kidney transplant patients,   March 13, 2025
  Hudson Therapeutics announces Shaperon to initiate phase 2b part 2 clinical trial of a topically administered drug, NuGel,   March 12, 2025
  Novo Nordisk announces results from REDEFINE 2 trial of CagriSema in people with obesity and type 2 diabetes,   March 12, 2025
  Arvinas & Pfizer announce positive topline results from phase 3 VERITAC-2 clinical trial,   March 12, 2025
  Trevi Therapeutics announces positive results from phase 2a RIVER trial of Haduvio in patients with refractory chronic cough,   March 11, 2025
  Bristol Myers Squibb presents late-breaking data from phase 3 POETYK PsA-2 trial demonstrating superiority of Sotyktu compared with placebo in adults with psoriatic arthritis at AAD meeting,   March 11, 2025
  Positive results from ADEPT phase 2/3 study of Dupixent in adults with moderate-to-severe bullous pemphigoid presented at AAD,   March 11, 2025
  Amgen & Kyowa Kirin positive results from rocatinlimab phase 3 IGNITE study in adults with moderate to severe atopic dermatitis,   March 11, 2025

  • Results Found: 16084
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 805
 Back
 
Avians_2025
chemexpoindia
ana-Lab-India_25
ProPak_Asia_2025
CPhI_Japan2025
CPHI_PMEC_China_2025
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram